Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,455 | 259 | 84.2% |
| Travel and Lodging | $979.89 | 3 | 15.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40.61 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,263 | 7 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $569.62 | 25 | $0 (2024) |
| EMD Serono, Inc. | $359.25 | 23 | $0 (2024) |
| ABBVIE INC. | $273.33 | 13 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $254.69 | 12 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $248.97 | 7 | $0 (2021) |
| GENZYME CORPORATION | $225.72 | 11 | $0 (2023) |
| UCB, Inc. | $224.12 | 10 | $0 (2020) |
| Akcea Therapeutics, Inc. | $202.86 | 4 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $201.28 | 24 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $693.50 | 28 | CATALYST PHARMACEUTICALS, INC. ($176.12) |
| 2023 | $581.25 | 27 | Lundbeck LLC ($84.64) |
| 2022 | $168.49 | 10 | ABBVIE INC. ($46.86) |
| 2021 | $491.97 | 21 | Teva Pharmaceuticals USA, Inc. ($163.77) |
| 2020 | $328.88 | 15 | Alexion Pharmaceuticals, Inc. ($117.41) |
| 2019 | $1,251 | 55 | Akcea Therapeutics, Inc. ($202.86) |
| 2018 | $841.51 | 44 | Alexion Pharmaceuticals, Inc. ($161.14) |
| 2017 | $2,119 | 64 | Medtronic Vascular, Inc. ($1,164) |
All Payment Transactions
264 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/30/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.00 | General |
| 09/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: EPILEPSY | ||||||
| 08/27/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Rare Disease | ||||||
| 08/12/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Immune | ||||||
| 08/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: Rare Disease | ||||||
| 08/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/06/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Adenosine A2A Receptors | ||||||
| 07/29/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Immune | ||||||
| 07/22/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $46.39 | General |
| Category: NEUROLOGY | ||||||
| 07/01/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $37.66 | General |
| Category: NEUROLOGY | ||||||
| 06/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/17/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $26.62 | General |
| Category: NEUROLOGY | ||||||
| 06/14/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $21.93 | General |
| Category: NEUROLOGY | ||||||
| 06/14/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $8.06 | General |
| Category: NEUROLOGY | ||||||
| 05/31/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.22 | General |
| Category: NEUROLOGY | ||||||
| 05/07/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $40.45 | General |
| Category: EPILEPSY | ||||||
| 04/23/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Rare Disease | ||||||
| 04/19/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $9.52 | General |
| Category: NEUROLOGY | ||||||
| 04/19/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $6.38 | General |
| Category: NEUROLOGY | ||||||
| 03/14/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 171 | 234 | $58,650 | $31,327 |
| 2022 | 5 | 208 | 279 | $72,730 | $39,085 |
| 2021 | 5 | 142 | 180 | $42,940 | $24,588 |
| 2020 | 5 | 142 | 200 | $45,070 | $21,862 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 53 | 106 | $21,200 | $10,682 | 50.4% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 34 | 34 | $17,000 | $8,412 | 49.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 62 | $10,850 | $7,495 | 69.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $9,600 | $4,738 | 49.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 70 | 133 | $26,600 | $13,895 | 52.2% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 40 | 40 | $20,000 | $10,177 | 50.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 62 | $10,850 | $7,412 | 68.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $9,300 | $4,749 | 51.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 13 | 13 | $5,980 | $2,851 | 47.7% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 37 | 71 | $14,200 | $7,629 | 53.7% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 23 | 23 | $11,500 | $6,147 | 53.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 48 | $8,400 | $5,844 | 69.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $6,600 | $3,541 | 53.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 16 | $2,240 | $1,427 | 63.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 82 | $14,350 | $7,502 | 52.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 28 | 56 | $11,200 | $5,211 | 46.5% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2020 | 19 | 19 | $9,500 | $4,701 | 49.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 25 | 25 | $7,500 | $3,196 | 42.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 18 | $2,520 | $1,252 | 49.7% |
About Dr. Tripta Sachdev, MD
Dr. Tripta Sachdev, MD is a Physical Medicine & Rehabilitation healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144288713.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tripta Sachdev, MD has received a total of $6,475 in payments from pharmaceutical and medical device companies, with $693.50 received in 2024. These payments were reported across 264 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($5,455).
As a Medicare-enrolled provider, Sachdev has provided services to 663 Medicare beneficiaries, totaling 893 services with total Medicare billing of $116,862. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location San Jose, CA
- Active Since 05/03/2006
- Last Updated 08/21/2014
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1144288713
Products in Payments
- SOLIRIS (Drug) $264.39
- FYCOMPA (Drug) $254.69
- APTIOM (Drug) $211.24
- TEGSEDI (Drug) $202.86
- Soliris (Drug) $185.48
- Rebif (Biological) $184.66
- Fycompa (Drug) $177.44
- TYSABRI (Biological) $174.25
- XARELTO (Drug) $165.41
- BOTOX (Biological) $143.50
- VYEPTI (Biological) $134.53
- Nucynta (Drug) $132.75
- AJOVY (Biological) $129.98
- ULTOMIRIS (Biological) $119.75
- Briviact (Drug) $117.39
- LYRICA (Drug) $115.40
- VALTOCO (Drug) $104.64
- AUBAGIO (Drug) $102.77
- Mavenclad (Biological) $101.10
- Reveal LINQ (Device) $98.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in San Jose
Dr. James Petros, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $9,646
Dr. Parvez Fatteh, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $5,163
Katherine Thomas, Md, MD
Physical Medicine & Rehabilitation — Payments: $5,000
Dr. Lakshmi Madireddi, Md, MD
Physical Medicine & Rehabilitation — Payments: $4,780
Dr. Michael Jadali, D.o. , Rph, D.O. , RPH
Physical Medicine & Rehabilitation — Payments: $4,170
Allen Kaisler-Meza, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $4,163